Complete Fertility Ltd, Southampton, United Kingdom; Human Development and Health, Faculty of Medicine, University of Southampton, Complete Fertility Ltd, Southampton, United Kingdom.
Complete Fertility Ltd, Southampton, United Kingdom; Human Development and Health, Faculty of Medicine, University of Southampton, Complete Fertility Ltd, Southampton, United Kingdom.
Best Pract Res Clin Obstet Gynaecol. 2018 Nov;53:3-10. doi: 10.1016/j.bpobgyn.2018.08.003. Epub 2018 Aug 25.
Intra-uterine insemination (IUI) is a cheaper, less intensive treatment modality for achieving a pregnancy in couples with specific indications. The use of IUI seems to have declined after NICE guideline 2013 (CG 156) recommended IVF over IUI in couples with unexplained and mild male factor infertility. This review examines the current evidence and the applicability of IUI as a first-line option of treatment in couples with unexplained and mild male factor subfertility. The outcome of the review supports this argument. It is likely that IUI will re-emerge as an effective treatment option and thereby increase the choice to patients. However, there is a need for ongoing research and investment into funding of good quality trials to improve and strengthen the evidence base.
宫腔内人工授精(IUI)是一种更经济、低强度的治疗方法,适用于具有特定适应证的夫妇妊娠。在 NICE 指南 2013(CG156)建议在不明原因和轻度男性因素不育的夫妇中选择 IVF 而非 IUI 之后,IUI 的使用似乎有所减少。本综述检查了目前的证据以及 IUI 在不明原因和轻度男性因素亚不育的夫妇中作为一线治疗选择的适用性。综述的结果支持这一观点。IUI 很可能重新成为一种有效的治疗选择,从而增加患者的选择。然而,需要进行持续的研究和投资,以资助高质量的试验,从而改善和加强证据基础。